Source: International Congress 2016 – Pulmonary arterial hypertension: future therapeutic approaches
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Harm Jan H.J. Bogaard (Amsterdam, Netherlands). Introduction: overview of pulmonary arterial hypertension pathogenesis. International Congress 2016 – Pulmonary arterial hypertension: future therapeutic approaches

Member's Comments

No comment yet.

Related content which might interest you: Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Pathogenesis of pulmonary arterial hypertension: lessons from cancer Source: Eur Respir Rev 2013; 22: 543-551 Year: 2013 Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Source: Eur Respir J 2010; 35: 730-734 Year: 2010 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 Pulmonary hypertension: pathophysiology and diagnosis Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007 Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020 Year: 2021 Schistosomiasis-associated pulmonary arterial hypertension: a systematic review Source: Eur Respir Rev, 29 (155) 190089; 10.1183/16000617.0089-2019 Year: 2020 Exercise pathophysiology in patients with pulmonary arterial hypertension Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 New insights in pulmonary vascular biology and pathophysiology Source: Annual Congress 2006 - Physiological year in review Year: 2006 Pulmonary arterial hypertension: an autoimmune disease? Source: Eur Respir J 2005; 26: 986-988 Year: 2005 LATE-BREAKING ABSTRACT: Evidence for a critical contribution of pericytes in pulmonary arterial hypertension pathogenesis Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010 Introduction: systemic effects in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 1S Year: 2003 Autoimmunity and pulmonary arterial hypertension: The role of leptin Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 CFTR involvement in the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Pulmonary arterial hypertension: bridging the present to the future Source: Eur Respir Rev 2012 21: 267-270 Year: 2012 Pulmonary arterial hypertension: treatment options Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED Year: 2018 Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007